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Introduction
Initial studies on vaccination against
Haemonchus contortus in 1997 have
shown that total worm protein extracts
were able to elicit a partially protective
immune response, however attempts to
enhance this response with a powerful
mucosal adjuvant namely E.coli heat-
labile enterotoxin (HLT) failed
(Hartina et al., in preparation). Based
on our findings and current literature it
was suggested that development of
anti-parasitic vaccines should empha-
sise studies on immunostimulants that
can enhance the response in the gut
rather than selecting protein antigens
from gel bands that were not likely to
elicit protective immunity. Using rapid
cell assay screening methods we have
discovered an aqueous extract from
Solanum torvum that is strongly mito-
genic for spleenic lymphocytes (Israf et
al., unpublished data). We have tested
this extract several times in a rodent-
non-replicating antigen model and have
shown that it is as effective as cholera
toxin in enhancing mucosal immune
responses. The results of these trials are
presented.
Materials and Methods
Three trials were conducted with out-
bred female IeR mice. In trial I, 10
groups of mice were given various
doses of Solanum extract as an adju-
vant to bovine serum albumin via the
intraperitoneal route. Boosters were
given and the immune response
throughout a 4-month period was ana-
lysed. In trial 2 and 3, mice received
similar doses as in trial 1 however the
route of inoculation was via oral ga-
vage. The main emphasis of these trials
was to examine the ability of Solanum
extracts to stimulate mucosal immune
effector mechanisms towards ovalbu-
min. Assays used included enzyme
immunoassay for detection of antibody
isotypes in various tissues and serum.
Enzyme immunospot was used to study
cytokine responses of lymphoid tissue
using monoclonal antibodies towards
IFM-y, IL-2,IL-4 and IL-5.
Results and Discussion
In trial I,we demonstrated a significant
enhancement in anti-BSA IgO titers
when the lowest dose of Solanum was
used (2 ug). We also demonstrated that
following a final booster, the intestinal
levels of both anti-BSA IgA and IgO
were significantly elevated. Trial 2
demonstrated that an oral booster with
ovalbumin/O.5 mg Solanum was able to
significantly elevate intestinal and
faecal IgA concentration and stimulate
both Thl and Th2 cells as determined
by analysis of cytokine production.
Trial 3 extended the findings of trial 2
in that it was shown that a very low
dose of Solanum (2 ug) administered
orally with ovalbumin was far more
superior in generating both local and
peripheral antibody and cytokine re-
sponses. This trial also demonstrated
that 2ug of Solanum could enhance
immune effector mechanisms in the
lung, an example of enhanced mucosal
homing. There is no doubt that this
extract is truly stimulatory for lympho-
cytes and has great potential to replace
the current mucosal adjuvants that are
more toxic in nature. We plan to ac-
quire further data on the mechanism of
action and study the enhancing effects
in a prototype Haemonchus vaccine.
Conclusions
Solanum extracts are very effective in
enhancing local and peripheral effector
mechanisms towards model protein
antigens. They target lymphocytes by
enhancing synthesis and secretion of
antibodies and cytokines. However our
data suggest that the crude extract
contain both immunostimulatory and
immunosuppressive factors. This the-
ory is based on the fact that a reduction
of the dose to as little as 2 ug leads to
enhanced responses. It is therefore
necessary to fractionate the compo-
nents for future studies.
Benefits from the study
We have developed the technology to
enhance mucosal immune responses by
coadministration of non-replicating
antigens with an aqueous plant extract.
This technology has the potential to
enhance the efficacy of vaccine prepa-
rations and allows for oral dosing
which is less traumatic and does not
require technical skilJ in administra-
tion.
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